Projects funded by the NCN
Modifiers of Muscleblind-like genes expression in health and disease.
2022/46/E/NZ5/00088
Keywords:
MBNL Muscleblind-like alternative splicing myotonic dystrophy transcription expression modulation molecular targeted therapy RNA activation (RNAa) CRISPR activation (CRISPRa)
Descriptors:
- NZ5_7: Human disease treatment
- NZ5_3: Pathogenesis of human diseases
- NZ5_9: Other related subjects
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii
woj. wielkopolskie
Principal investigator (from the host institution):
dr hab. Ewa Stępniak-Konieczna
Number of co-investigators in the project: 5
Call: SONATA BIS 12 - announced on 2022-05-15
Amount awarded: 4 842 802 PLN
Project start date (Y-m-d): 2023-11-29
Project end date (Y-m-d): 2028-11-28
Project duration:: 60 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.